Artiva Biotherapeutics Competitors and Similar CompaniesClear all
Immutep's competitors and similar companies include Bexion Pharmaceuticals and Numab.
 Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment. |  Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. | ||
Founding Date | Founding Date 2001 | Founding Date 2006 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE | Locations Covington, US HQ | Locations Wädenswil, CH HQ |
Employees | Employees 2427% decrease | Employees 274% increase | Employees 681% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 16.6m (about 7 years ago) | Latest funding round $ 110m (about 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 16.6m | Total funding raised $ 132.3m |
For sources of this data, please see the company profile
View Company Profiles
Bexion Pharmaceuticals
HQ
Covington, US
Employees
27↑ 4% increase
Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
View company
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View company